Health Canada Approves ZEPOSIA®, an Oral Treatment for Relapsing Remitting Multiple Sclerosis Biotech Investing
Mydecine Innovations Group Announces Filing of Provisional Patent for the Treatment of PTSD with Psilocybin Psychedelics Investing
Medtronic Announces Adaptix Interbody System, the First Navigated Titanium Cage with Titan nanoLOCK Surface Technology Medical Device Investing
Opdivo Plus Chemotherapy Shows Statistically Significant Improvement in Pathologic Complete Response as Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial Biotech Investing
Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment Pharmaceutical Investing
Omar Ishrak to Retire as Medtronic Executive Chairman and Chairman of the Board; Geoff Martha to Succeed Ishrak as Chairman of the Board, Effective December 11, 2020 Medical Device Investing
Medtronic Announces First Patient Implanted in ELITE Study of InterStim Micro Medical Device Investing
Hollister Biosciences 100% Owned Subsidiary Venom Extracts Achieves Initial $30 Million Revenue Milestone Psychedelics Investing
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
